Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Preset: moving averages 50 and 200 (on the daily chart the 50- and 200-day lines), plus volume. You can add further indicators in the chart yourself.Academy: 200-day line · RSI
About the company
Cardinal Health is a major pharmaceutical wholesaler from Ohio. It supplies pharmacies, hospitals and doctors’ offices in the US with medicines and also makes medical supplies. It also provides services for specialist physicians and logistics. As of Oct 11, 2026
As of Oct 11, 2026Fact sheet (from the annual report)Wholesale of drugs and drugstore products · Dublin, USAfull fact sheet
Cardinal Health is a healthcare products and services company founded in 1979 and incorporated in Ohio. Its customers are hospitals, hospital networks, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients at home. The pharmaceutical division, with by far the larger share of revenue in fiscal year 2026, distributes branded, generic and specialty drugs as well as over-the-counter products in the US. The pharmaceutical margin comes from discounts, rebates and fees from generic manufacturers and from distribution fees paid by branded manufacturers, among other sources. The medical products division makes or sources private-label items and, in the US and Canada, also supplies branded products of other manufacturers to hospitals and other healthcare providers. Other areas run nuclear pharmacies, supply chronically ill patients at home and organize shipping for healthcare providers.
Our own calculation from the exchange’s daily candles, as of Nov 20, 2026. “All-time” applies since the start of this series, not to the whole market. Changes in percent; the TradingView chart shows prices. “Today” = change of the last trading day versus the previous day. Not investment advice.
Fundamentals · Analysis method
Growth, margin, balance sheet, cash flow and dividend compared with the sector – with traffic lights and quality checks in the fundamental analysis. To the fundamental analysis ↓
Fundamental analysis
SEC filing (10-K, 10-Q)Required reports of listed companies to the US Securities and Exchange Commission (SEC): 10-K is the annual report, 10-Q the quarterly report, 20-F the annual report of foreign companies. We show the figures of the first filing.Example: 10-K for the fiscal year ending Sep 27, 2025, filed on Oct 31, 2025.More in the Academy: Lesson revenue, profit and margin
Cardinal Health · Sector Health Care · amounts in USD
Source: SEC filings, As of Aug 11, 2026.
Investor typeInvestor type (“lens”)You choose which style comes first: dividends, valuation, growth, quality or trading. Screener and stock page then show suggestions and “For you first”, with an account also matching columns and order. The lens unlocks nothing and changes no matches.Example: Lens “Dividends” → on the stock page first the streak without a cut, growth and cover of the dividend.More in the Academy: Guide fundamental analysis
For you firstDividend
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 9.4x.
Four angles on the annual figures. Each check counts how many disclosed criteria are met – criteria without data do not count. The bars show where the company ranks on each figure among the stocks we cover and within its sector.
–no data: Return on equity above 15%negative equity
✗not met: Free cash flow margin above 10%1.8%
✗not met: Profit in each of the last 5 fiscal years4 of 5
✓met: Free cash flow positive in each of the last 3 fiscal years3 of 3
✗not met: Equity ratio above 30%−5.0%
Gross margin
3.8%Fiscal year 2026
All2weak
Rank 2 of 100: higher than 2% of 370 peers (All). weak.
Sector5weak
Rank 5 of 100: higher than 5% of 49 peers (Sector). weak.
Median Health Care: 61.8%
Share of revenue left after the direct cost of the products sold.
Operating margin
1.0%Fiscal year 2026
All17weak
Rank 17 of 100: higher than 17% of 470 peers (All). weak.
Sector16weak
Rank 16 of 100: higher than 16% of 54 peers (Sector). weak.
Median Health Care: 17.0%
Operating income divided by revenue: what the core business earns before interest and taxes.
Net margin
0.7%Fiscal year 2026
All14weak
Rank 14 of 100: higher than 14% of 584 peers (All). weak.
Sector15weak
Rank 15 of 100: higher than 15% of 63 peers (Sector). weak.
Median Health Care: 12.9%
Profit after all costs, interest and taxes divided by revenue.
Return on assets
3.0%Fiscal year 2026 (total assets at year end)
All34medium
Rank 34 of 100: higher than 34% of 594 peers (All). medium.
Sector18weak
Rank 18 of 100: higher than 18% of 63 peers (Sector). weak.
Median Health Care: 6.6%
Net income divided by total assets at fiscal year end.
Equity ratio
−5.0%Fiscal year 2026
All4weak
Rank 4 of 100: higher than 4% of 595 peers (All). weak.
Sector6weak
Rank 6 of 100: higher than 6% of 63 peers (Sector). weak.
Median Health Care: 44.2%
Equity as a share of total assets. Usually low for banks.
Free cash flow margin
1.8%Fiscal year 2026
All19weak
Rank 19 of 100: higher than 19% of 465 peers (All). weak.
Sector16weak
Rank 16 of 100: higher than 16% of 61 peers (Sector). weak.
Median Health Care: 14.5%
Free cash flow divided by revenue.
Free cash flow
4.5B USDFiscal year 2026
Operating cash flow minus capital expenditure on property and equipment.
Growth 7 of 7 met
✓met: Over 3 years, revenue grew by more than 5% per year+7.4%
✓met: Over 5 years, revenue grew by more than 5% per year+9.4%
✓met: Over 10 years, revenue grew by more than 5% per year+7.7%
✓met: Over 3 years, EPS grew by more than 5% per year+93.4%
✓met: Over 5 years, EPS grew by more than 5% per year+28.3%
✓met: Revenue rose in at least 4 of the last 5 fiscal years4 of 5
✓met: Revenue rose in the last fiscal year+14.2%
Revenue growth 3 years
+7.4%per year
All57medium
Rank 57 of 100: higher than 57% of 578 peers (All). medium.
Sector62medium
Rank 62 of 100: higher than 62% of 62 peers (Sector). medium.
Median Health Care: +5.1%
Average growth per year over 3 fiscal years.
Revenue growth 5 years
+9.4%per year
All55medium
Rank 55 of 100: higher than 55% of 549 peers (All). medium.
Sector58medium
Rank 58 of 100: higher than 58% of 60 peers (Sector). medium.
Median Health Care: +7.8%
Average growth per year over 5 fiscal years.
Revenue growth 10 years
+7.7%per year
All59medium
Rank 59 of 100: higher than 59% of 412 peers (All). medium.
Sector33medium
Rank 33 of 100: higher than 33% of 50 peers (Sector). medium.
Median Health Care: +9.3%
Average growth per year over 10 fiscal years.
EPS growth 3 years
+93.4%per year
All98strong
Rank 98 of 100: higher than 98% of 437 peers (All). strong.
Sector95strong
Rank 95 of 100: higher than 95% of 54 peers (Sector). strong.
Median Health Care: +5.0%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 5 years
+28.3%per year
All86strong
Rank 86 of 100: higher than 86% of 399 peers (All). strong.
Sector93strong
Rank 93 of 100: higher than 93% of 47 peers (Sector). strong.
Median Health Care: +8.3%
Growth of earnings per share per year, adjusted for stock splits.
EPS growth 10 years
+5.3%per year
All29weak
Rank 29 of 100: higher than 29% of 375 peers (All). weak.
Sector29weak
Rank 29 of 100: higher than 29% of 46 peers (Sector). weak.
Median Health Care: +9.3%
Growth of earnings per share per year, adjusted for stock splits.
Dividend 7 of 7 met
✓met: Pays a dividend2.04 USD
✓met: Payout ratio at most 60% of earnings28%
✓met: Dividend paid in each of the last 5 fiscal years5 of 5
✓met: Dividend per share never lowered in the last 5 fiscal yearsDividend per share as filed with the SEC, including special dividends; a one-off higher prior year does not count as a cut.never
✓met: Dividend per share higher than 5 years ago+1.0%
✓met: Free cash flow per share covers the dividend9.4x
✓met: Dividends paid over the last 5 years covered by free cash flow17% of free cash flow
Payout ratio
28%Fiscal year 2026
Dividend per share divided by earnings per share.
Dividend growth 5 years
+1.0%per year
All10weak
Rank 10 of 100: higher than 10% of 321 peers (All). weak.
Sector15weak
Rank 15 of 100: higher than 15% of 31 peers (Sector). weak.
Median Health Care: +6.6%
Growth of the dividend per share per year.
Free cash flow coverage
9.4xFiscal year 2026
Free cash flow per share divided by dividend per share. From 1x the dividend is covered.
Financial strength 2 of 6 met
✗not met: Piotroski F-Score at least 7 of 96 of 9
✗not met: Long-term debt no higher than equitynegative equity
✗not met: Current assets cover current liabilities0.88
✗not met: Positive equity−2.9B USD
✓met: In 5 years, share count up by at most 5%−19.4%
✓met: Free cash flow positive in the last fiscal year4.5B USD
Piotroski F-Score
6 of 9Fiscal year 2026
All45medium
Rank 45 of 100: higher than 45% of 310 peers (All). medium.
Sector38medium
Rank 38 of 100: higher than 38% of 47 peers (Sector). medium.
Median Health Care: 6.0 of 9
Nine yes/no tests on profit, cash flow, debt, liquidity and efficiency compared with the prior year.
Debt / equity
negative equityat fiscal year end
No rank: too few peers or not computed yet.
Long-term financial debt divided by equity.
Liquidity (current ratio)
0.88at fiscal year end
All19weak
Rank 19 of 100: higher than 19% of 513 peers (All). weak.
Sector10weak
Rank 10 of 100: higher than 10% of 63 peers (Sector). weak.
Median Health Care: 1.58
Current assets divided by current liabilities.
Change in share count
−19.4%in 5 years
All90strong
Rank 90 of 100: lower than 90% of 507 peers (All). strong.
Sector91strong
Rank 91 of 100: lower than 91% of 59 peers (Sector). strong.
Median Health Care: −4.3%
Change in diluted share count. Negative = share buybacks, positive = new shares.
The 9 criteria of the Piotroski F-Score
✓met: Profit in the last fiscal year (positive return on assets)
✓met: Positive operating cash flow
✗not met: Return on assets higher than the prior year
✓met: Operating cash flow higher than net income
✓met: Long-term debt relative to total assets fell
✗not met: Liquidity (current assets / current liabilities) rose
✓met: No additional shares (diluted share count did not rise)
✓met: Gross margin higher than the prior year
✗not met: Revenue relative to total assets higher than the prior year
Last fiscal year compared with the one before. Returns and revenue per total assets use total assets at the start of the year; leverage = long-term financial debt divided by total assets at year end; new shares via the average diluted share count.
Price-based criteria (P/E, dividend yield) are shown to signed-in users.
Computed automatically from SEC annual reports – not investment advice. Describes the reported figures; points are not a rating of the stock. Rank 0–100 against the 239 stocks we cover and against the sector (from 5 peers); the stronger side is always on the right.
In short
Light green: Revenue grew over 5 years (+9.4% per year), at least as fast as the sector median.
Light green: Net income (total) grew over 5 years (+22.9% per year), at least as fast as the sector median; per share +28.3% per year.
Light yellow: Net margin 0.7%, below the sector median (13.9%).
Light red: Profit in 8 of 10 fiscal years.
Summarized from the lights below. Describes the reported figures – not a recommendation to buy or sell.
RevenueNet incomeNet margin (below)in USD
0100B200B300B
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Revenue 130.0B USD · Net income 1.3B USD · Net margin 1.0%
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Revenue 136.8B USD · Net income 256.0M USD · Net margin 0.2%
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Revenue 145.5B USD · Net income 1.4B USD · Net margin 0.9%
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Revenue 152.9B USD · Net income −3.7B USD · Net margin −2.4%
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Revenue 162.5B USD · Net income 611.0M USD · Net margin 0.4%
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Revenue 181.4B USD · Net income −933.0M USD · Net margin −0.5%
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Revenue 205.0B USD · Net income 261.0M USD · Net margin 0.1%
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Revenue 226.8B USD · Net income 852.0M USD · Net margin 0.4%
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Revenue 222.6B USD · Net income 1.6B USD · Net margin 0.7%
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 254.2B USD · Net income 1.7B USD · Net margin 0.7%
Margin
1.0%0.2%0.9%−2.4%0.4%−0.5%0.1%0.4%0.7%0.7%
RevenueNet incomeNet margin (below)in USD
020B40B60B80B
Q2/23Quarter Q2/23 (Apr 1, 2023 – Jun 30, 2023): Revenue 53.5B USD · Net income −64.0M USD · Net margin −0.1% · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Revenue 54.8B USD · Net income 5.0M USD · Net margin 0.0%
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Revenue 57.4B USD · Net income 353.0M USD · Net margin 0.6%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Revenue 54.9B USD · Net income 258.0M USD · Net margin 0.5%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Revenue 59.7B USD · Net income 236.0M USD · Net margin 0.4% · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Revenue 52.3B USD · Net income 416.0M USD · Net margin 0.8%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Revenue 55.3B USD · Net income 400.0M USD · Net margin 0.7%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Revenue 54.9B USD · Net income 506.0M USD · Net margin 0.9%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Revenue 60.2B USD · Net income 239.0M USD · Net margin 0.4% · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Revenue 64.0B USD · Net income 450.0M USD · Net margin 0.7%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Revenue 65.6B USD · Net income 467.0M USD · Net margin 0.7%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Revenue 67.5B USD · Net income 554.0M USD · Net margin 0.8%
Margin
−0.1%0.0%0.6%0.5%0.4%0.8%0.7%0.9%0.4%0.7%0.7%0.8%
Earnings per shareUSD per share
−15−10−5.0005.0010
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Earnings per share 4.03 USD
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Earnings per share 0.81 USD
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Earnings per share 4.53 USD
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Earnings per share −12.61 USD
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Earnings per share 2.08 USD
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Earnings per share −3.35 USD
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Earnings per share 1.00 USD
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Earnings per share 3.45 USD
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Earnings per share 6.45 USD
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Earnings per share 7.23 USD
Earnings per shareUSD per share
01.002.003.00
Q2/23Quarter Q2/23 (Apr 1, 2023 – Jun 30, 2023): Earnings per share not reported separately for Q4
Dividend per sharePayout ratio (below)USD per share
01.002.003.00
2017Fiscal year 2017 (Jul 1, 2016 – Jun 30, 2017): Dividend per share 1.80 USD · Payout ratio 44.7%
2018Fiscal year 2018 (Jul 1, 2017 – Jun 30, 2018): Dividend per share 1.85 USD · Payout ratio 228.4%
2019Fiscal year 2019 (Jul 1, 2018 – Jun 30, 2019): Dividend per share 1.91 USD · Payout ratio 42.2%
2020Fiscal year 2020 (Jul 1, 2019 – Jun 30, 2020): Dividend per share 1.92 USD · Payout ratio not available
2021Fiscal year 2021 (Jul 1, 2020 – Jun 30, 2021): Dividend per share 1.94 USD · Payout ratio 93.3%
2022Fiscal year 2022 (Jul 1, 2021 – Jun 30, 2022): Dividend per share 1.96 USD · Payout ratio not available
2023Fiscal year 2023 (Jul 1, 2022 – Jun 30, 2023): Dividend per share 1.98 USD · Payout ratio 198.0%
2024Fiscal year 2024 (Jul 1, 2023 – Jun 30, 2024): Dividend per share 2.00 USD · Payout ratio 58.0%
2025Fiscal year 2025 (Jul 1, 2024 – Jun 30, 2025): Dividend per share 2.02 USD · Payout ratio 31.3%
2026Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Dividend per share 2.04 USD · Payout ratio 28.2%
Ratio
45%228%42%93%198%58%31%28%
Dividend per sharePayout ratio (below)USD per share
00.200.400.60
Q2/23Quarter Q2/23 (Apr 1, 2023 – Jun 30, 2023): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/23Quarter Q3/23 (Jul 1, 2023 – Sep 30, 2023): Dividend per share 0.50 USD · Payout ratio 2,503.0%
Q4/23Quarter Q4/23 (Oct 1, 2023 – Dec 31, 2023): Dividend per share 0.50 USD · Payout ratio 33.4%
Q1/24Quarter Q1/24 (Jan 1, 2024 – Mar 31, 2024): Dividend per share 0.50 USD · Payout ratio 46.8%
Q2/24Quarter Q2/24 (Apr 1, 2024 – Jun 30, 2024): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/24Quarter Q3/24 (Jul 1, 2024 – Sep 30, 2024): Dividend per share 0.51 USD · Payout ratio 29.7%
Q4/24Quarter Q4/24 (Oct 1, 2024 – Dec 31, 2024): Dividend per share 0.51 USD · Payout ratio 30.6%
Q1/25Quarter Q1/25 (Jan 1, 2025 – Mar 31, 2025): Dividend per share 0.51 USD · Payout ratio 24.1%
Q2/25Quarter Q2/25 (Apr 1, 2025 – Jun 30, 2025): Dividend per share not available · Payout ratio not available · Q4 derived (year minus 9 months), may be distorted by restatements
Q3/25Quarter Q3/25 (Jul 1, 2025 – Sep 30, 2025): Dividend per share 0.51 USD · Payout ratio 27.2%
Q4/25Quarter Q4/25 (Oct 1, 2025 – Dec 31, 2025): Dividend per share 0.51 USD · Payout ratio 25.9%
Q3/26Quarter Q3/26 (Jul 1, 2026 – Sep 30, 2026): Dividend per share 0.52 USD · Payout ratio 21.7%
Ratio
2,503%33%47%30%31%24%27%26%22%
Fiscal year 2026 (Jul 1, 2025 – Jun 30, 2026): Revenue 254.2B USD · Net income 1.7B USD · Net margin 0.7%
How has it gone since the last annual report?
Trailing 12 months and quarters
Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Revenue in the quarter to Sep 2026 +5.5% vs. the same quarter a year earlier.
Revenue 12 months vs. prior 12Trailing 12 monthsFigures for the latest twelve months: fiscal year plus the months since it ended minus the same months a year earlier, each from the first SEC filing. More current than the fiscal year, but not audited. P/E, PEG and the checks still use the fiscal year.Example: Fiscal year $400M, 9 months after it $330M, same 9 months a year earlier $300M → 400 + 330 − 300 = $430M.More in the Academy: Lesson trailing twelve months
Free cash flow margin 12 monthsFree cash flowCash from operations minus investment in property, plant and equipment. It shows how much money is left over – for repaying debt, dividends or share repurchases.Example: Operating cash flow 120 million euros, investments 45 million euros → free cash flow 75 million euros.More in the Academy: Guide fundamental analysis
1.9%
Fiscal year 2026: 1.8%
More depth
Calculation of the 12 months to Sep 30, 2026
Revenue: fiscal year to Jun 30, 2026 254.2B USD + year to date to Sep 30, 2026 67.5B USD − same period a year earlier to Sep 30, 2025 64.0B USD = 257.8B USD
Net income: fiscal year to Jun 30, 2026 1.7B USD + year to date to Sep 30, 2026 554.0M USD − same period a year earlier to Sep 30, 2025 450.0M USD = 1.8B USD
Operating cash flow: fiscal year to Jun 30, 2026 5.2B USD + year to date to Sep 30, 2026 1.4B USD − same period a year earlier to Sep 30, 2025 973.0M USD = 5.6B USD
Capital expenditure: fiscal year to Jun 30, 2026 649.0M USD + year to date to Sep 30, 2026 157.0M USD − same period a year earlier to Sep 30, 2025 108.0M USD = 698.0M USD
By quarter (latest first, amounts in USD)
Quarter
Revenue
vs. year ago
Net income
Margin
Jul–Sep 26
67.5B
+5.5%
554.0M
0.8%
Oct–Dec 25
65.6B
+18.8%
467.0M
0.7%
Jul–Sep 25
64.0B
+22.4%
450.0M
0.7%
Apr–Jun 25*
60.2B
+0.8%
239.0M
0.4%
Jan–Mar 25
54.9B
−0.1%
506.0M
0.9%
Oct–Dec 24²
55.3B
−3.8%
400.0M
0.7%
Jul–Sep 24²
52.3B
−4.5%
416.0M
0.8%
Apr–Jun 24*
59.7B
+11.7%
236.0M
0.4%
Trailing 12 months = last fiscal year + the period since the start of the current fiscal year − the same period a year earlier, each from the first filing. P/E, PEG and the quality checks still use the last fiscal year.
Each quarter is compared with the same quarter a year earlier.
* derived: fiscal year minus the first 9 months.
² Year-ago quarter restated after a spin-off or divestiture – compared with the restated figure from the same report.
As of: 12 months to Sep 30, 2026, filed on Nov 5, 2026 · Source: SEC filings (10-Q, 10-K)
Does the profit arrive as cash?
Earnings quality
Profit is backed by cash; interest is well covered.
Cash flow ÷ profitCash flow ÷ profitOperating cash flow divided by group profit. From 1.0, at least as much cash came in as profit was reported; below that, profit may sit in receivables or inventories, and non-cash gains or one-off payments also push the ratio down. Depreciation and stock-based pay lift it.Example: Operating cash flow €120m, group profit €100m → 1.20x.More in the Academy: Lesson earnings quality
3.03x
0.81.0
backed from 1.0 · 3 years: 2.75x
Interest coverageInterest coverageOperating income divided by interest expense: how many times the core business earns its interest. From 5x we count interest as well covered, below 2x as thinly covered.Example: Operating income €50m, interest expense €5m → 10.0x.More in the Academy: Lesson earnings quality
7.5x
25
well covered from 5 · 3 years: 10.0x
Tax rateTax rateIncome taxes divided by profit before tax, in percent. If the SEC data lack it, we approximate it as group profit plus taxes; minority interests, discontinued operations, one-off items and tax credits can shift the rate.Example: Taxes €21m, net income €79m → 21 : 100 = 21%.More in the Academy: Lesson earnings quality
How it is rated: cash flow ÷ profit from 1.0 “backed by cash”, below 0.8 “profit well above the cash coming in”; interest coverage from 5 “well covered”, below 2 “thinly covered”. The tax rate is only shown.
Cash flow ÷ profit uses group profit incl. minority interests, because cash flow also covers the whole group. Profit before tax as reported to the SEC, otherwise approximated. “3 years” = sums of the last three fiscal years – only if every year is reported and the figures have the same origin; for cash flow only with a profit in every year.
As of fiscal year 2026 · Source: SEC filings
How even were the last years?
Consistency
In 10 fiscal years 2 loss years and one year with lower revenue.
Loss yearsLoss yearsFiscal years that ended with a loss on the bottom line (net income below zero). Few loss years over a long period show how evenly a company has earned so far – they say nothing about the future.Example: Loss only in fiscal year 2020 → 1 of 10.More in the Academy: Lesson revenue, profit and margin
2 of 10
net income below zero
Years with lower revenueYear with lower revenueA fiscal year in which revenue was lower than in the prior year. Only years for which the prior year’s revenue is also reported are counted.Example: Revenue 100 → €96m → one year with lower revenue.More in the Academy: Lesson revenue, profit and margin
1 of 10
revenue below the prior year
Net margin rangeNet margin rangeHighest minus lowest net margin of the fiscal years shown, in percentage points. A small range means the share of profit in revenue stayed similar over the years.Example: Net margins between 18.2% and 26.4% → range 8.2 percentage points.More in the Academy: Lesson revenue, profit and margin
3.4 percentage points
from −2.4% to 1.0%
▾20172026Net margin by fiscal year · ▾ revenue below the prior yearMore depth
By fiscal year
FY
Revenue vs. prior year
Net margin
2026
+14.2%
0.7%
2025
−1.9%
0.7%
2024
+10.6%
0.4%
2023
+13.0%
0.1%
2022
+11.6%
−0.5%
2021
+6.2%
0.4%
2020
+5.1%
−2.4%
2019
+6.4%
0.9%
2018
+5.3%
0.2%
2017
+6.9%
1.0%
Loss year: net income below zero. Lower revenue: revenue below the prior year. Range: highest minus lowest net margin; margins beyond ±200% do not count. No score – only the reported figures.
As of fiscal years 2017–2026 · Source: SEC filings
Figures over time
Where the money of a fiscal year goes and how margins, returns, balance sheet, cash flow and share count developed over up to 10 years. Each chart has one sentence saying what the trend shows.
Money flow in fiscal year 2026
Of 100 USD of revenue, 3.8 USD gross profit, 1.0 USD operating income and 0.7 USD net income remained.
2017Fiscal year 2017: Operating cash flow 1.2B USD · Capital expenditure 387.0M USD · Free cash flow 797.0M USD
2018Fiscal year 2018: Operating cash flow 2.8B USD · Capital expenditure 384.0M USD · Free cash flow 2.4B USD
2019Fiscal year 2019: Operating cash flow 2.7B USD · Capital expenditure 328.0M USD · Free cash flow 2.4B USD
2020Fiscal year 2020: Operating cash flow 2.0B USD · Capital expenditure 375.0M USD · Free cash flow 1.6B USD
2021Fiscal year 2021: Operating cash flow 2.4B USD · Capital expenditure 400.0M USD · Free cash flow 2.0B USD
2022Fiscal year 2022: Operating cash flow 3.1B USD · Capital expenditure 387.0M USD · Free cash flow 2.7B USD
2023Fiscal year 2023: Operating cash flow 2.8B USD · Capital expenditure 481.0M USD · Free cash flow 2.4B USD
2024Fiscal year 2024: Operating cash flow 3.8B USD · Capital expenditure 511.0M USD · Free cash flow 3.3B USD
2025Fiscal year 2025: Operating cash flow 2.4B USD · Capital expenditure 547.0M USD · Free cash flow 1.9B USD
2026Fiscal year 2026: Operating cash flow 5.2B USD · Capital expenditure 649.0M USD · Free cash flow 4.5B USD
Share count
The share count fell in 5 years by 19.4% (mostly through share repurchases).
Diluted share count
0100M200M300M400M
2017Fiscal year 2017: Diluted share count 320.0M
2018Fiscal year 2018: Diluted share count 315.0M
2019Fiscal year 2019: Diluted share count 301.0M
2020Fiscal year 2020: Diluted share count 293.0M
2021Fiscal year 2021: Diluted share count 294.0M
2022Fiscal year 2022: Diluted share count 279.0M
2023Fiscal year 2023: Diluted share count 262.0M
2024Fiscal year 2024: Diluted share count 247.0M
2025Fiscal year 2025: Diluted share count 242.0M
2026Fiscal year 2026: Diluted share count 237.0M
From annual reports filed with the SEC (10-K, 20-F, 40-F) as first reported, share count adjusted for splits; obvious filing errors (e.g. wrong unit, outliers against both neighbouring years) are hidden. Describes the reported figures – not investment advice.
Metrics chart
Metrics chartUp to three metrics stacked, each with its own axis, over the same fiscal years. Optionally a second stock (dashed or hatched) and today’s sector median as a mark in the latest year – we do not have earlier medians.Example: Revenue rises, net margin falls, share count falls → more business, less profit per unit of revenue, fewer shares (mostly through buybacks).More in the Academy: Guide fundamental analysis
Up to three metrics stacked over the same fiscal years – so you see at a glance whether they rise together or drift apart. Point at a year to read it in every panel.
Revenue
Revenue rose in 5 years from 162.5B USD to 254.2B USD.
CAHin USD
0100B200B300B
2017Fiscal year 2017: CAH 130.0B USD
2018Fiscal year 2018: CAH 136.8B USD
2019Fiscal year 2019: CAH 145.5B USD
2020Fiscal year 2020: CAH 152.9B USD
2021Fiscal year 2021: CAH 162.5B USD
2022Fiscal year 2022: CAH 181.4B USD
2023Fiscal year 2023: CAH 205.0B USD
2024Fiscal year 2024: CAH 226.8B USD
2025Fiscal year 2025: CAH 222.6B USD
2026Fiscal year 2026: CAH 254.2B USD
Earnings per share
Earnings per share rose in 5 years from 2.08 USD to 7.23 USD.
CAHUSD per share
−15−10−5.0005.0010
2017Fiscal year 2017: CAH 4.03 USD
2018Fiscal year 2018: CAH 0.81 USD
2019Fiscal year 2019: CAH 4.53 USD
2020Fiscal year 2020: CAH −12.61 USD
2021Fiscal year 2021: CAH 2.08 USD
2022Fiscal year 2022: CAH −3.35 USD
2023Fiscal year 2023: CAH 1.00 USD
2024Fiscal year 2024: CAH 3.45 USD
2025Fiscal year 2025: CAH 6.45 USD
2026Fiscal year 2026: CAH 7.23 USD
Share count
The share count fell in 5 years by 19.4% (mostly through share repurchases).
CAH
0100M200M300M400M
2017Fiscal year 2017: CAH 320.0M
2018Fiscal year 2018: CAH 315.0M
2019Fiscal year 2019: CAH 301.0M
2020Fiscal year 2020: CAH 293.0M
2021Fiscal year 2021: CAH 294.0M
2022Fiscal year 2022: CAH 279.0M
2023Fiscal year 2023: CAH 262.0M
2024Fiscal year 2024: CAH 247.0M
2025Fiscal year 2025: CAH 242.0M
2026Fiscal year 2026: CAH 237.0M
Source: SEC filings, fiscal years up to Jun 30, 2026. The same figures as in the sections of this page, per fiscal year as first reported. Describes the reported figures – not investment advice.
How reliable is the dividend?
Dividend at a glance
The dividend per share was never cut as far as our annual data goes (10 years in a row); free cash flow per share covers it 9.4x.
Years without a cutYears without a dividend cutHow many fiscal years in a row up to the latest the dividend per share has not fallen, adjusted for stock splits. Only 1% less than the year before counts as a cut, a special dividend in the prior year does not. If the run reaches the start of our data, “at least” is shown.Example: Dividend 1.10 – 0.90 – 0.95 – 1.00 – 1.05 € → 3 years without a cut since the cut.More in the Academy: Lesson debt, dividends and growth
at least 10
as far as the data goes
Growth per year (5 yrs)Dividend growthHow much the dividend per share has risen on average per year, calculated over 5 fiscal years. Only for companies that paid a dividend in the last fiscal year.Example: Dividend €1.00 five years ago, €1.40 today → 7.0% per year.More in the Academy: Lesson debt, dividends and growth
+1.0%
dividend per share, average per year
Coverage by free cash flowDividend coverage by free cash flowFree cash flow per share divided by dividend per share. From 1x, the cash freely available in a year covers the dividend; below that, the company pays out more than is left over. We do not calculate it for the financial sector.Example: Free cash flow €3.00 per share, dividend €2.00 → 1.5x.More in the Academy: Lesson debt, dividends and growth
9.4x
1
covered from 1.0x
You can see the dividend yield and shareholder yield (based on the price) with a free account.Sign up free
More depth
Calculation
Dividend per share: fiscal year 2021 1.94 USD → fiscal year 2026 2.04 USD = +1.0% per year
Free cash flow per share 19.09 USD ÷ dividend per share 2.04 USD = 9.4x
Years without a cut: in a row up to fiscal year 2026, dividend per share according to the SEC, adjusted for stock splits; only 1% less than the year before counts as a cut, also for variable dividends; a special dividend in the prior year does not. If the dividend per share falls while the total paid rises, the run ends as “unclear”. “At least” is shown only if our data ends earlier.
Shareholder yield: dividends paid plus share repurchases minus proceeds from new shares according to the cash flow statement of the last fiscal year, divided by today’s market value. Missing repurchases or new shares count as 0; without reported dividend or repurchase payments (among others for many stocks of the extended selection) there is no value. Describes the reported figures – not investment advice.
Valuation against its own historyWhere P/E, P/S or price/free cash flow stands today compared with the median of the company’s own last 5 fiscal years, in percent. Up to 10% deviation counts as “about at the median”. Describes only the position, not a judgement on an appropriate price.Example: P/E today 22, own 5-year median 27 → 22 ÷ 27 − 1 = −18.5%, so below the median.More in the Academy: Lesson cheaper or pricier than usual?
The P/E is above its own median of the 5 fiscal years before.
With a free account you can see how far – and the same for P/S and price/free cash flow, with the calculation.Sign up free
Source: SEC filings and our daily candles
Dividends and share repurchases
How much the company returns to its shareholders – as dividends or by repurchasing its own shares – and whether free cash flow supports it.
Dividend per share
2.04USD · Fiscal year 2026
Dividend growth per year
3 y+1.0%5 y+1.0%10 y+2.8%
Payout ratio
of earnings28%of free cash flow11%
To shareholders (5 years)
8.4B USD70% through repurchases
Share count over 5 years
−19.4%fewer shares – each share is a larger stake
Dividend per share
The dividend per share rose in 5 years from 1.94 USD to 2.04 USD.
Dividend per shareUSD per sharePer share as filed with the SEC, including special dividends; obvious filing errors are hidden.
01.002.003.00
2017Fiscal year 2017: Dividend per share 1.80 USD
2018Fiscal year 2018: Dividend per share 1.85 USD
2019Fiscal year 2019: Dividend per share 1.91 USD
2020Fiscal year 2020: Dividend per share 1.92 USD
2021Fiscal year 2021: Dividend per share 1.94 USD
2022Fiscal year 2022: Dividend per share 1.96 USD
2023Fiscal year 2023: Dividend per share 1.98 USD
2024Fiscal year 2024: Dividend per share 2.00 USD
2025Fiscal year 2025: Dividend per share 2.02 USD
2026Fiscal year 2026: Dividend per share 2.04 USD
Payout ratios
The payout ratio fell in 5 years from 93.3% to 28.2%.
Payout ratio (earnings)Payout ratio (free cash flow)
0%100%200%300%
2017Fiscal year 2017: Payout ratio (earnings) 44.7% · Payout ratio (free cash flow) 72.4%
2018Fiscal year 2018: Payout ratio (earnings) 228.4% · Payout ratio (free cash flow) 24.4%
2019Fiscal year 2019: Payout ratio (earnings) 42.2% · Payout ratio (free cash flow) 24.1%
2020Fiscal year 2020: Payout ratio (earnings) not available · Payout ratio (free cash flow) 35.9%
2021Fiscal year 2021: Payout ratio (earnings) 93.3% · Payout ratio (free cash flow) 28.2%
2022Fiscal year 2022: Payout ratio (earnings) not available · Payout ratio (free cash flow) 20.4%
2023Fiscal year 2023: Payout ratio (earnings) 198.0% · Payout ratio (free cash flow) 22.3%
2024Fiscal year 2024: Payout ratio (earnings) 58.0% · Payout ratio (free cash flow) 15.3%
2025Fiscal year 2025: Payout ratio (earnings) 31.3% · Payout ratio (free cash flow) 26.7%
2026Fiscal year 2026: Payout ratio (earnings) 28.2% · Payout ratio (free cash flow) 10.9%
What goes back to shareholders
Over 5 years, 8.4B USD went back to shareholders, 70% of it through share repurchases. That is 57% of the free cash flow of those years.
2017Fiscal year 2017: Dividends paid 577.0M USD · Share repurchases 600.0M USD · New shares issued (including employee plans) not available · Free cash flow 797.0M USD
2018Fiscal year 2018: Dividends paid 581.0M USD · Share repurchases 550.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
2019Fiscal year 2019: Dividends paid 577.0M USD · Share repurchases 600.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
2020Fiscal year 2020: Dividends paid 569.0M USD · Share repurchases 350.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.6B USD
2021Fiscal year 2021: Dividends paid 573.0M USD · Share repurchases 200.0M USD · New shares issued (including employee plans) not available · Free cash flow 2.0B USD
2022Fiscal year 2022: Dividends paid 559.0M USD · Share repurchases 1.0B USD · New shares issued (including employee plans) not available · Free cash flow 2.7B USD
2023Fiscal year 2023: Dividends paid 525.0M USD · Share repurchases 2.0B USD · New shares issued (including employee plans) not available · Free cash flow 2.4B USD
2024Fiscal year 2024: Dividends paid 499.0M USD · Share repurchases 750.0M USD · New shares issued (including employee plans) not available · Free cash flow 3.3B USD
2025Fiscal year 2025: Dividends paid 494.0M USD · Share repurchases 765.0M USD · New shares issued (including employee plans) not available · Free cash flow 1.9B USD
2026Fiscal year 2026: Dividends paid 491.0M USD · Share repurchases 1.4B USD · New shares issued (including employee plans) not available · Free cash flow 4.5B USD
Dividends paid, repurchases and new shares issued from the cash flow statement of annual reports filed with the SEC (as first reported). Describes the reported figures – not investment advice.
Valuation over time
Price-based valuation (P/E, P/S, price/free cash flow and dividend yield per fiscal year, compared with its own average) for signed-in users.Log in
Sector comparison
Cardinal Health next to 8 stocks of the sector Health Care we cover that are closest in revenue. Click a column header to sort the table.
Sector comparison CAH, sector Health Care; last row: sector median
Figures of the last fiscal year from SEC annual reports (peers as of Nov 22, 2026). Median across all companies of the sector we cover (from 5 stocks; several share classes of one company count once). Signed-in users also see P/E, P/S and dividend yield in the comparison. Describes the reported figures – not investment advice.
Key figures with traffic lights
Each light follows a simple, disclosed rule. The comparison is with the sector median Sector medianThe middle value of all companies in a sector: half are above it, half below. Unlike the average, single outliers hardly distort it.Example: Margins 4%, 8%, 10%, 12%, 60% → median 10%, average 18.8%.More in the Academy: Lesson putting the P/E in context of all 26 symbols in the Health Care sector on our list (current members of the S&P 500 and other lists).
Revenue growth
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+9.4%per year, last 5 years
Sector Health Care: median +8.5% (25 symbols)
What does this mean? Revenue: over 5 years it grew by 9.4% per year on average – at least as fast as the median company in the sector (+8.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
Net income (total)
Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth
Light green: above sector
+22.9%per year, last 5 years
Sector Health Care: median +5.5% (20 symbols)
per share: +28.3% per year (5 years, split-adjusted)
What does this mean? Total net income: over 5 years it grew by 22.9% per year on average – at least as fast as the median company in the sector (+5.5%).
Light rule: Green: grows at least as fast as the sector median (without a sector comparison: grows) · Yellow: grows more slowly · Red: shrinks.
What does this mean? Of every 100 USD in revenue, 0.67 USD remained as profit – less than the median company in the sector (13.9%). Five years ago the margin was 0.4%.
Light rule: Green: at least the sector median (without a sector comparison: profit) · Yellow: profit, but below the median · Red: loss.
Debt / equity
Debt-to-equity ratioFinancial debt (loans, bonds) divided by equity. A high value amplifies good and bad years alike. The key figures bar in the chart only uses long-term financial debt.Example: Financial debt €300m, equity €500m → 0.6.More in the Academy: Lesson debt, dividends and growth
Light gray: negative equity
–latest balance sheet
Sector Health Care: median 0.66 (19 symbols)
What does this mean? Equity is negative (e.g. due to share buybacks). A debt-to-equity ratio cannot be formed meaningfully then.
Light rule: Green: at most the sector median · Yellow: up to twice the median · Red: more than twice · Gray: without a sector comparison.
Payout ratio
Payout ratioThe share of profit that a company pays out as a dividend. Above 100% it pays out more than it earns.Example: Dividend €1, earnings per share €2.50 → payout ratio 40%.More in the Academy: Lesson debt, dividends and growth
Light green: covered
28%Dividend / earnings per share
Sector Health Care: median 56% (16 symbols)
What does this mean? Of every 1 USD of earnings per share, 0.28 USD went to shareholders as a dividend. The rest stays in the company. Median company in the sector: 56%.
Light rule: Green: up to 60% of earnings · Yellow: up to 100% · Red: more than earnings or a dividend despite a loss · Gray for real estate (REITs). The sector median is for comparison only.
Profitable years
Profitable yearsHow many of the last fiscal years ended with a profit rather than a loss on the bottom line. The figure shows how consistently a company earns.Example: Profit in 9 of 10 years → one loss year.More in the Academy: Lesson revenue, profit and margin
Light red: 2 loss years
8 of 10fiscal years with a profit
What does this mean? In 8 of the last 10 fiscal years the bottom line showed a profit. 2 years ended with a loss.
Light rule: Green: profit in every year · Yellow: one loss year · Red: several loss years (at least 3 years needed).
Last fiscal year and 13F
Information, not a trading signal · Source: SEC EDGAR
Revenue (FY)
254.2B USD
Revenue vs. prior year
+14.2%
Net income (FY)
1.7B USD
Net income vs. prior year
+9.8%
EPS (FY)
7.23 USD
Superinvestors holding
3 of 26
Fiscal year to Jun 30, 2026 · 10-K filed Aug 11, 2026 · Price-based figures (P/E, P/S, dividend yield, market cap) only when logged in. · Values as first reported; debt = reported financial debt (US GAAP: long-term).Superinvestors: 26 tracked investors per 13F filing (as of quarter end, filed up to 45 days later); weight and change per investor in the card “Which superinvestors hold …?”.
All figures as a table
Fiscal years (amounts in USD, per share in USD)
Year
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
2026
Jun 30, 2026
254.2B
1.7B
0.7%
7.23
2.04
28%
2025
Jun 30, 2025
222.6B
1.6B
0.7%
6.45
2.02
31%
2024
Jun 30, 2024
226.8B
852.0M
0.4%
3.45
2.00
58%
2023
Jun 30, 2023
205.0B
261.0M
0.1%
1.00
1.98
198%
2022
Jun 30, 2022
181.4B
−933.0M
−0.5%
−3.35
1.96
–
2021
Jun 30, 2021
162.5B
611.0M
0.4%
2.08
1.94
93%
2020
Jun 30, 2020
152.9B
−3.7B
−2.4%
−12.61
1.92
–
2019
Jun 30, 2019
145.5B
1.4B
0.9%
4.53
1.91
42%
2018
Jun 30, 2018
136.8B
256.0M
0.2%
0.81
1.85
228%
2017
Jun 30, 2017
130.0B
1.3B
1.0%
4.03
1.80
45%
Quarters (amounts in USD, per share in USD)
Quarter
End
Revenue
Net income
Margin
Earnings per share
Dividend per share
Payout
Q3/26
Sep 30, 2026
67.5B
554.0M
0.8%
2.38
0.52
22%
Q4/25
Dec 31, 2025
65.6B
467.0M
0.7%
1.97
0.51
26%
Q3/25
Sep 30, 2025
64.0B
450.0M
0.7%
1.88
0.51
27%
Q2/25*
Jun 30, 2025
60.2B
239.0M
0.4%
–
–
–
Q1/25
Mar 31, 2025
54.9B
506.0M
0.9%
2.10
0.51
24%
Q4/24
Dec 31, 2024
55.3B
400.0M
0.7%
1.65
0.51
31%
Q3/24
Sep 30, 2024
52.3B
416.0M
0.8%
1.70
0.51
30%
Q2/24*
Jun 30, 2024
59.7B
236.0M
0.4%
–
–
–
Q1/24
Mar 31, 2024
54.9B
258.0M
0.5%
1.07
0.50
47%
Q4/23
Dec 31, 2023
57.4B
353.0M
0.6%
1.50
0.50
33%
Q3/23
Sep 30, 2023
54.8B
5.0M
0.0%
0.02
0.50
2,503%
Q2/23*
Jun 30, 2023
53.5B
−64.0M
−0.1%
–
–
–
* Q4 derived: fiscal year minus the 9-month value (EPS cannot be derived this way); may be distorted by restatements.
How we calculate: values as first reported to the SEC (later corrections are left out), a fixed order of reporting tags per figure, partial sums are never added up. Growth per year Growth per year (CAGR)The average annual growth rate over several years, as if the value had grown equally strongly every year. Individual good or bad years even out in it.Example: Revenue €100m → €161m in 5 years → (161 ÷ 100) to the power of 1/5 − 1 = 10% per year.More in the Academy: Lesson debt, dividends and growth over 5 years (otherwise 3 years). Quarters are labeled by the calendar quarter in which they end.
Information only – does not affect the other analysis methods, not investment advice.
Insiders
Insider transactionsExecutives, directors and major shareholders (over 10%) of US companies report their own transactions in their company’s stock to the SEC within two business days (Form 4). Purchases in the market count as more meaningful than sales (often taxes, estate planning).Example: Three executives acquire stock worth a total of 2 million USD within two weeks → “purchases by several insiders”.More in the Academy: Glossary
Insider purchases and sales on the market over 3, 6 and 12 months
Period
Purchases
Sales
Net
3 months
$00 people
$00 people
$0
6 months
$00 people
$59.6M7 people
−$59.6M
12 months
$00 people
$61.6M8 people
−$61.6M
Latest transactions
Aug 19, 2026Scherer Mary C.OfficerOpen-market sale2,202 shares · $522.7K · SEC
Aug 19, 2026Scherer Mary C.OfficerOpen-market sale100 shares · $23.7K · SEC
Aug 19, 2026Hollar Jason M.Chief executive (CEO)Open-market sale6,244 shares · $1.5M · SEC
Aug 19, 2026Hollar Jason M.Chief executive (CEO)Open-market sale16,187 shares · $3.8M · SEC
Aug 19, 2026Hollar Jason M.Chief executive (CEO)Open-market sale6,731 shares · $1.6M · SEC
Aug 19, 2026Hollar Jason M.Chief executive (CEO)Open-market sale5,704 shares · $1.3M · SEC
Source: mandatory filings with the SEC (Form 4), open-market purchases and sales only. General information, not investment advice.
Which superinvestors hold Cardinal Health?
Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
Source: 13F filing with the US Securities and Exchange Commission, latest filing dated Nov 16, 2026. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included.
Trend score –
We do not calculate a trend score for symbols in the extended universe.
Volatility and trend strength
ADX 14 (trend strength)–
Price change 60 days–
ATR ATR (Average True Range)The average range per trading day over the last 14 days. It makes distances comparable, whether a stock costs 10 or 1,000.Example: ATR 2.50 at a price of 100: 0.4 ATR is 1.00, i.e. 1%.More in the Academy: Lesson ATR and moving averages as price values only when logged in.